We are pleased to inform you that the first External Quality Assessment (EQA) Scheme for Basophil Activation Test (BAT) is now available.
- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
BUHLMANN News
An outstanding research paper was published in the top rated Journal of Allergen and Clinical Immunology which evaluated the performance of basophil activation as a biomarker in monitoring clinical efficacy of oral peanut immunotherapy in a clinical trial.
BÜHLMANN fCAL® turbo + CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 98839 CALEX® Cap CALEX® Cap is an FDA 510(k) cleared fecal extraction device for use with BÜHLMANN fCAL® turbo that provides excellent correlation to the traditional manual weighing method and offers efficient, convenient and hygienic extraction of stool samples. Its unique design
Continue Reading
BÜHLMANN fCAL® ELISA Citation Lara Hart et al. Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis, Journal of Crohn's and Colitis, Volume 14, Issue 1, January 2020, DOI: doi.org/10.1093/ecco-jcc/jjz107 READ CITATION BÜHLMANN fCAL® ELISA is FDA 510(k) cleared For in vitro Diagnostic Use. Health Canada License: 80726 This citation describes applications that are outside of
Continue Reading
Page 5 of 27 « 1 … 3 4 5 6 7 … 27 »Sorry,You have not added any story yet References Chiba A et al. Latov N et al Ilyas, AA et al.
Continue Reading
IBDoc® Citation: Avery, P. et. al. N05: IBDoc® Faecal calprotectin self-test retrospective audit in a District General Hospital (DGH). ECCO 2020, Feb 12-15. Highlights from this Publication “ …This data also helps separate well from unwell patients, offering further opportunities to promote supported self-management in people with IBD and prioritisation of clinic appointments....” Read Citation Health
Continue Reading
IBDoc® Citation: S. Jäghult et. al. N08: IBD Home at GHP Stockholm Gastro Center in Sweden. ECCO 2020, Feb 12-15. Highlights from this Publication “ …The majority (n = 24) stated that it was easy to install IBD Home. A total of nine patients noted that their participation in their own health care had increased...” “
Continue Reading
BÜHLMANN IBDoc®: Sugrue, K. et al. N12: An evaluation of the impact of IBDoc in clinical practice 5 years after introduction. ECCO 2020, Feb 12 – 15, 2020. Vienna, Austria. Highlights from this Publication “This study shows the benefits of using IBDoc® in clinical practice. It is central to facilitating a fast track system for patients
Continue Reading
